Jonathan G. Drachman, See Remarks at Neoleukin Therapeutics, Inc. (NLTX), bought 500,000 shares at $2.85 ($1.6M) on 2019-09-09, disclosed to the SEC on 2019-09-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 76,822 | $219K | 14.0% |
| 2 | $2.85 | 76,822 | $219K | 14.0% |
| 3 | $3.08 | 36,742 | $113K | 7.2% |
| 4 | $3.08 | 36,742 | $113K | 7.2% |
| 5 | $3.30 | 136,436 | $450K | 28.8% |
| 6 | $3.30 | 136,436 |
| $450K |
| 28.8% |
| Total | $3.13 avg | 500,000 | $1.6M | 100% |
| Filing → |
| NLTX | BUY | 2021-06-07 | $475K | — | Filing → |
| NLTX | BUY | 2019-12-20 | $2.0M | — | Filing → |
| SGEN | SELL | 2018-03-07 | $725K | — | Filing → |